52532192,,62031664,21435928,,20522562,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532193,,62031664,21435987,,20522656,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532194,,62031664,21435926,,20522558,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532195,,62031664,21435930,,20522564,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532196,,62031664,21435931,,20522565,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532197,,62031664,21435924,,20522555,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532198,,62031664,21435997,,20522671,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532199,,62031664,21435999,,20522673,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532200,,62031664,21435979,,20522643,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532201,,62031664,21435984,,20522650,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532202,,62031664,21435982,,20522647,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532203,,62031664,21435934,,20522570,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532204,,62031664,21435998,,20522672,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532205,,62031664,21435993,,20522666,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532206,,62031664,21435953,,20522602,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532207,,62031664,21435936,,20522572,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532208,,62031664,21435974,,20522638,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532209,,62031664,21435996,,20522670,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532210,,62031664,21435943,,20522586,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532211,,62031664,21435968,,20522630,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532212,,62031664,21435939,,20522577,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532213,,62031664,21435957,,20522607,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532214,,62031664,21435992,,20522665,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532215,,62031664,21435958,,20522609,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532216,,62031664,21435989,,20522659,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532217,,62031664,21435988,,20522658,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532218,,62031664,21435991,,20522663,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532219,,62031664,21435980,,20522644,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532220,,62031664,21435971,,20522634,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532221,,62031664,21435929,,20522563,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532222,,62031664,21435947,,20522593,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532223,,62031664,21435967,,20522626,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532224,,62031664,21435994,,20522667,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532225,,62031664,21435985,,20522651,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532226,,62031664,21435986,,20522653,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532227,,62031664,21436008,,24744026,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532228,,62031664,21436009,,24744028,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532229,,62031664,21436010,,24744030,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532230,,62031664,21436011,,24744031,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532231,,62031664,21436012,,24744032,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532232,,62031664,21436013,,24744033,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532233,,62031664,21436014,,24744034,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532234,,62031664,21436015,,24744035,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532235,,62031664,21435927,,20522559,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532238,,62031664,21435935,,20522571,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532239,,62031664,21435938,,20522575,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532240,,62031664,21435937,,20522574,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532242,,62031664,21435920,,20522546,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532244,,62031664,21435942,,20522585,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532245,,62031664,21435964,,20522622,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532247,,62031664,21435949,,20522597,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532248,,62031664,21435941,,20522583,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532249,,381061,21436029,MAIN,18526926,2536147,,,,,,,,7169023,qualitative,,6089845,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532251,,381061,21436020,MAIN,1281606,495821,,,,,,,,7169023,qualitative,,6089845,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532252,,62031664,21435981,,20522645,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532253,,381061,21436036,MAIN,6830318,5,,,,,,,,7169023,qualitative,,6089845,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532254,,62031664,21435932,,20522567,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532255,,381061,21436030,MAIN,18526927,2536148,,,,,,,,7169023,qualitative,,6089845,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532257,,381061,21436021,MAIN,1411176,1445020,,,,,,,,7169023,qualitative,,6089845,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532258,,62031664,21435973,,20522637,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532259,,381061,21436034,MAIN,6248989,1624312,,,,,,,,7169023,qualitative,,6089845,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532260,,62031664,21436004,,24743987,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532261,,381061,21436029,MAIN,18526926,2536147,,,,,,,,7169022,qualitative,,6089843,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532262,,62031664,21436005,,24743990,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532263,,381061,21436036,MAIN,6830318,5,,,,,,,,7169022,qualitative,,6089843,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532264,,62031664,21436006,,24743993,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532265,,381061,21436030,MAIN,18526927,2536148,,,,,,,,7169022,qualitative,,6089843,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532266,,62031664,21436007,,24743996,,,,,,,,,7169016,Emax,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,>=,30,,%,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532267,,381061,21436021,MAIN,1411176,1445020,,,,,,,,7169022,qualitative,,6089843,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532268,,62031664,21435919,,20522545,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532269,,381061,21436034,MAIN,6248989,1624312,,,,,,,,7169022,qualitative,,6089843,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532270,,62031664,21435923,,20522550,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532271,,62031664,21435921,,20522547,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532272,,381061,21436020,MAIN,1281606,495821,,,,,,,,7169022,qualitative,,6089843,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532273,,62031664,21435918,,20522544,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532274,,381061,21436026,MAIN,18526923,MH,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532275,,381061,21436024,MAIN,18526922,2536143,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532276,,62031664,21435948,,20522596,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532277,,62031664,21435966,,20522625,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532278,,381061,21436028,MAIN,18526925,2536146,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532279,,381061,21436033,MAIN,6176346,1620304,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532280,,62031664,21436000,,20522675,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532281,,381061,21436023,MAIN,18526921,2536142,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532282,,62031664,21435970,,20522633,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532283,,381061,21436038,MAIN,92210,1418354,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532284,,62031664,21435976,,20522640,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532285,,62031664,21435922,,20522549,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532286,,381061,21436031,MAIN,4809306,1520960,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532287,,62031664,21435951,,20522599,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532288,,381061,21436027,MAIN,18526924,2536145,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532289,,62031664,21435959,,20522610,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532290,,381061,21436032,MAIN,5808429,1589847,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532291,,62031664,21435950,,20522598,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532292,,381061,21436039,MAIN,9774317,12,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532293,,62031664,21435952,,20522600,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532294,,381061,21436022,MAIN,1681307,1448683,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532295,,62031664,21435956,,20522606,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532296,,381061,21436037,MAIN,81566,1417630,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532297,,62031664,21435944,,20522587,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532298,,381061,21436020,MAIN,1281606,495821,,,,,,,,7169024,qualitative,,6089846,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect :   FimHtr,,,,,,,,,,,,,,,,,,,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532299,,381061,21436029,MAIN,18526926,2536147,,,,,,,,7169021,qualitative,,6089847,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532300,,62031664,21435946,,20522592,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532301,,62031664,21435945,,20522591,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532302,,381061,21436020,MAIN,1281606,495821,,,,,,,,7169021,qualitative,,6089847,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532303,,62031664,21435961,,20522616,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532304,,381061,21436035,MAIN,6830318,1672827,,,,,,,,7169021,qualitative,,6089847,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532305,,62031664,21435995,,20522669,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532306,,381061,21436030,MAIN,18526927,2536148,,,,,,,,7169021,qualitative,,6089847,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532307,,62031664,21435983,,20522648,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532308,,381061,21436021,MAIN,1411176,1445020,,,,,,,,7169021,qualitative,,6089847,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532309,,62031664,21435990,,20522661,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532310,,381061,21436034,MAIN,6248989,1624312,,,,,,,,7169021,qualitative,,6089847,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532311,,62031664,21435960,,20522614,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532312,,381061,21436029,MAIN,18526926,2536147,,,,,,,,7169020,qualitative,,6089844,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532313,,62031664,21435963,,20522619,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532314,,381061,21436035,MAIN,6830318,1672827,,,,,,,,7169020,qualitative,,6089844,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532315,,62031664,21436003,,20522679,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532316,,381061,21436030,MAIN,18526927,2536148,,,,,,,,7169020,qualitative,,6089844,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532317,,381061,21436021,MAIN,1411176,1445020,,,,,,,,7169020,qualitative,,6089844,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532318,,62031664,21436002,,20522677,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532319,,381061,21436034,MAIN,6248989,1624312,,,,,,,,7169020,qualitative,,6089844,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532320,,62031664,21435975,,20522639,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532321,,381061,21436020,MAIN,1281606,495821,,,,,,,,7169020,qualitative,,6089844,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532322,,62031664,21436001,,20522676,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532323,,62031664,21435955,,20522605,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532324,,381061,21436025,MAIN,18526923,2536144,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532325,,381061,21436024,MAIN,18526922,2536143,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532326,,62031664,21435940,,20522582,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532327,,381061,21436028,MAIN,18526925,2536146,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532328,,62031664,21435977,,20522641,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532329,,381061,21436033,MAIN,6176346,1620304,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532330,,62031664,21435925,,20522557,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532331,,381061,21436023,MAIN,18526921,2536142,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532332,,62031664,21435928,,20522562,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532333,,381061,21436038,MAIN,92210,1418354,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532334,,62031664,21435987,,20522656,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532335,,381061,21436031,MAIN,4809306,1520960,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532336,,62031664,21435926,,20522558,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532337,,381061,21436027,MAIN,18526924,2536145,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532338,,62031664,21435930,,20522564,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532339,,381061,21436032,MAIN,5808429,1589847,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532340,,62031664,21435931,,20522565,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532341,,381061,21436040,MAIN,9774317,1950697,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532342,,62031664,21435924,,20522555,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532343,,381061,21436022,MAIN,1681307,1448683,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532344,,62031664,21435997,,20522671,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532345,,381061,21436037,MAIN,81566,1417630,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532346,,62031664,21435999,,20522673,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532347,,381061,21436020,MAIN,1281606,495821,,,,,,,,7169019,qualitative,,6089842,In Vitro (others),In Vitro (others),In Vitro (Efficacy),,,,Effect : FimHtr,,1806897,,,,,Escherichia coli,,,,,,,,,,,Escherichia coli,,,title compound was bound by FimHtr,,,,,,,,,,2018/11/16,,,2020/03/12,
52532348,,62031664,21435979,,20522643,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532349,,62031664,21435984,,20522650,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532350,,62031664,21435982,,20522647,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532351,,62031664,21435934,,20522570,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532352,,62031664,21435998,,20522672,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532353,,62031664,21435993,,20522666,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532354,,62031664,21435953,,20522602,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532355,,62031664,21435936,,20522572,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532356,,62031664,21435974,,20522638,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532357,,62031664,21435996,,20522670,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532358,,62031664,21435943,,20522586,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532359,,62031664,21435968,,20522630,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532360,,62031664,21435939,,20522577,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532361,,62031664,21435957,,20522607,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532362,,62031664,21435992,,20522665,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532363,,62031664,21435958,,20522609,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532364,,62031664,21435989,,20522659,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532365,,62031664,21435988,,20522658,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532366,,62031664,21435991,,20522663,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532367,,62031664,21435980,,20522644,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532368,,62031664,21435971,,20522634,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532369,,62031664,21435929,,20522563,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532370,,62031664,21435947,,20522593,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532371,,62031664,21435967,,20522626,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532372,,62031664,21435994,,20522667,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532373,,62031664,21435985,,20522651,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532374,,62031664,21435986,,20522653,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532375,,62031664,21436008,,24744026,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532376,,62031664,21436009,,24744028,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532377,,62031664,21436010,,24744030,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532378,,62031664,21436011,,24744031,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532379,,62031664,21436012,,24744032,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532380,,62031664,21436013,,24744033,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532381,,62031664,21436014,,24744034,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532382,,62031664,21436015,,24744035,,,,,,,,,7169017,qualitative,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,Not Published,,,,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532383,,62031664,21435927,,20522559,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532386,,62031664,21435935,,20522571,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532387,,62031664,21435938,,20522575,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532388,,62031664,21435937,,20522574,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532390,,62031664,21435920,,20522546,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532392,,62031664,21435942,,20522585,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532393,,62031664,21435964,,20522622,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532395,,62031664,21435949,,20522597,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532396,,62031664,21435941,,20522583,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532398,,62031664,21435981,,20522645,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532399,,62031664,21435932,,20522567,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532401,,62031664,21435973,,20522637,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532402,,62031664,21436004,,24743987,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532403,,62031664,21436005,,24743990,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532404,,62031664,21436006,,24743993,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532405,,62031664,21436007,,24743996,,,,,,,,,7169018,Emax,,6089841,,Agonistic activity,In Vitro (Efficacy),,,Agonist,Agonistic activity of the compound towards alpha-2A adrenergic receptor expressed in CHO-K1 cells using [35S]GTPgammaS as radioligand in presence of GDP upon incubation in assay buffer for 30 min at RT,,1806895,CHO-K1 cell line,,,,,3844722,,Alpha 2A adrenoceptor,,Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor:Wild,Alpha 2A adrenoceptor,,,,,,,<=,30,,%,,,,,,2018/11/16,Alpha 2A adrenoceptor,1,2018/11/22,
52532406,,384464,21436045,MAIN,18527333,,,,,,,,,7169025,qualitative,,6089849,,Cell/tumor cell: proliferation/viability/growth,In Vitro (Efficacy),,,,cell proliferation; inhibition of,antiproliferative agent,,,,,,,,,,,,,,,,,,,,effect of cell proliferation inhibition was additive (figure),ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532407,,384464,21436041,MAIN,18527329,,,,,,,,,7169025,qualitative,,6089849,,Cell/tumor cell: proliferation/viability/growth,In Vitro (Efficacy),,,,cell proliferation; inhibition of,antiproliferative agent,,,,,,,,,,,,,,,,,,,,title compound decreased cell proliferation (figures),ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532408,,384464,21436042,MAIN,18527330,,,,,,,,,7169026,EC50,,6089849,,Cell/tumor cell: proliferation/viability/growth,In Vitro (Efficacy),,,,cell proliferation; inhibition of,antiproliferative agent,,,,,,,,,,,,,,,,,,,,effect of cell proliferation inhibition was additive (figure),,0.5 - 1.5,,µM,6.3,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532409,,384464,21436044,MAIN,18527332,,,,,,,,,7169026,EC50,,6089849,,Cell/tumor cell: proliferation/viability/growth,In Vitro (Efficacy),,,,cell proliferation; inhibition of,antiproliferative agent,,,,,,,,,,,,,,,,,,,,effect of cell proliferation inhibition was additive (figure),,1,,µM,6,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532410,,384464,21436043,MAIN,18527331,,,,,,,,,7169026,EC50,,6089849,,Cell/tumor cell: proliferation/viability/growth,In Vitro (Efficacy),,,,cell proliferation; inhibition of,antiproliferative agent,,,,,,,,,,,,,,,,,,,,,,4,,µM,5.4,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532411,,384464,21436046,MAIN,8187721,,,,,,,,,7169027,qualitative,,6089848,,,In Vitro (Efficacy),,,,cell proliferation; increase in,,,,,,,,,,,,,,,,,,,,,title compound increased cell proliferation (figure),ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532412,,379193,21436048,MAIN,18526412,,oral administration,,,,,,,7169028,qualitative,,6089856,,,In Vivo (Animal models),,,,acne; reduction of,,1806898,,,,,human,,,,,,,,,,,human,,,title compound reduced acne,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532413,,379193,21436048,MAIN,18526412,,oral administration,,,,,,,7169029,qualitative,,6089852,,,In Vivo (Animal models),,,,blood pressure; decrease in,,1806898,,,,,human,,,,,,,,,,,human,,,title compound decreased blood pressure in patients with elevated blood pressure,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532414,,379193,21436048,MAIN,18526412,,oral administration,,,,,,,7169030,qualitative,,6089855,,,In Vivo (Animal models),,,,energy; increase in,,1806898,,,,,human,,,,,,,,,,,human,,,title compound increased natural level of energy,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532415,,379193,21436048,MAIN,18526412,,oral administration,,,,,,,7169031,qualitative,,6089857,,,In Vivo (Animal models),,,,face flushing; prevention of,,1806898,,,,,human,,,,,,,,,,,human,,,title compound prevented face flushing after alcohol consumption,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532416,,379193,21436048,MAIN,18526412,,oral administration,,,,,,,7169032,qualitative,,6089850,,,In Vivo (Animal models),,,,hangover; prevention of,,1806898,,,,,human,,,,,,,,,,,human,,,title compound prevented hangover after alcohol consumption,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532417,,379193,21436048,MAIN,18526412,,oral administration,,,,,,,7169033,qualitative,,6089851,,,In Vivo (Animal models),,,,metal alertness; improvement of,,1806898,,,,,human,,,,,,,,,,,human,,,title compound improved metal alertness and attention,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532418,,379193,21436048,MAIN,18526412,,oral administration,,,,,,,7169034,qualitative,,6089859,,,In Vivo (Animal models),,,,sleep quality; improvement of,,1806898,,,,,human,,,,,,,,,,,human,,,title compound improved sleep quality,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532419,,379193,21436048,MAIN,18526412,,oral administration,,,,,,,7169035,qualitative,,6089854,,,In Vivo (Animal models),,,,paracetamol-induced hepatotoxicity; reduction of,,1806899,,,,,rat,,,,,,,,,,,rat,,,title compound reduced paracetamol-induced hepatotoxicity,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532420,,379193,21436048,MAIN,18526412,,oral administration,,,,,,,7169036,qualitative,,6089858,,,In Vivo (Animal models),,,,paracetamol-induced increases in liver aspartate aminotransferase (ASAT); reduction of,,1806899,,,,,rat,,,,,,,,,,,rat,,,title compound reduced paracetamol-induced increases in liver aspartate aminotransferase (ASAT),ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532421,,379193,21436047,MAIN,18526412,,,,,,,,,7169037,qualitative,,6089853,,,In Vitro (Efficacy),,,,ACE; inhibition of,,,,,,,,,,,,,,,,,,,,,"title compound prepared by 300 or 200 diafiltration showed IC50 for ACE inhibition of 203.23 mg/L or 133.47 mg/L, respectively",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532422,,379168,21436049,MAIN,9154761,1887752,oral administration,,,,,,,7169039,qualitative,,6089861,In vivo Measurement,In vivo Measurement,In Vivo (Animal models),,,,Effect : allergic asthma symptoms/exacerbation; effect on  ,,1806900,,,,,human,,,,,,,,,,,human,,,"treatment with the title compound can reduce the severity of allergic asthma symptoms, exacerbations, delay the onset, reduce the number and the severity of allergic asthma symptoms/exacerbations",,,,,,,,,,2018/11/16,,,2018/11/22,
52532423,,379168,21436050,MAIN,9455577,1919695,oral administration,,,,,,,7169040,qualitative,,6089862,In vivo Measurement,In vivo Measurement,In Vivo (Animal models),,,,Effect : allergic asthma symptoms; effect on  ,,1806900,,,,,human,,,,,,,,,,,human,,,treatment with the title compound starting before the presumed onset of the allergic season (and continued treatment during the season) reduced the allergic asthma symptoms severity,,,,,,,,,,2018/11/16,,,2018/11/22,
52532424,,379168,21436050,MAIN,9455577,1919695,oral administration,,,,,,,7169038,qualitative,,6089860,In vivo Measurement,In vivo Measurement,In Vivo (Animal models),,,,Effect : asthma; effect on  ,,1806900,,,,,human,,,,,,,,,,,human,,,treatment with the title compound reduce the asthma disease burden,,,,,,,,,,2018/11/16,,,2018/11/22,
52532444,,61963990,21436157,,19938596,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532445,,61963990,21436334,,24183754,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532446,,61963990,21436118,,19938553,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532447,,61963990,21436156,,19938595,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532448,,61963990,21436119,,19938554,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532449,,61963990,21436167,,19938606,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532450,,61963990,21436115,,19938548,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532451,,61963990,21436078,,19938495,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532452,,61963990,21436112,,19938544,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532453,,61963990,21436144,,19938581,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532454,,61963990,21436332,,24183717,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532455,,61963990,21436129,,19938565,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532456,,61963990,21436214,,19938659,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532457,,61963990,21436134,,19938570,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532458,,61963990,21436231,,19938676,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532459,,61963990,21436150,,19938589,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532460,,61963990,21436077,,19938487,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532461,,61963990,21436059,,19747500,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532462,,61963990,21436204,,19938647,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532463,,61963990,21436143,,19938580,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532464,,61963990,21436254,,19938707,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532465,,61963990,21436137,,19938573,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532466,,61963990,21436184,,19938625,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532467,,61963990,21436146,,19938583,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532468,,61963990,21436196,,19938638,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532469,,61963990,21436061,,19747502,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532470,,61963990,21436145,,19938582,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532471,,61963990,21436185,,19938626,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532472,,61963990,21436075,,19747522,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532473,,61963990,21436060,,19747501,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532474,,61963990,21436070,,19747514,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532475,,61963990,21436258,,19938711,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532476,,61963990,21436128,,19938564,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532477,,61963990,21436123,,19938558,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532478,,61963990,21436199,,19938641,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532479,,61963990,21436056,,19747497,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532480,,61963990,21436212,,19938657,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532481,,61963990,21436151,,19938590,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532482,,457374,21436388,MAIN,18527728,AFAP40,,,,,,,,7169083,qualitative,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,the title compound shows cytotoxicity,,,,,,,,,,2018/11/16,,,2018/11/22,
52532483,,61963990,21436253,,19938703,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532484,,61963990,21436232,,19938677,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532485,,457374,21436363,MAIN,17627998,HC11,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,0.5,,µM,6.3,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532486,,61963990,21436297,,19938755,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532487,,457374,21436367,MAIN,18010546,AFAP62,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,15.2,,µM,4.82,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532488,,61963990,21436181,,19938622,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532489,,61963990,21436255,,19938708,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532490,,457374,21436355,MAIN,11329613,MMS6,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,19,,µM,4.72,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532491,,457374,21436370,MAIN,18010702,AFAP64,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,4.2,,µM,5.38,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532492,,61963990,21436347,,25548338,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532493,,61963990,21436136,,19938572,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532494,,457374,21436366,MAIN,18010533,AFAP42,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,4.5,,µM,5.35,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532495,,61963990,21436126,,19938561,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532496,,457374,21436380,MAIN,18527720,AFAP57,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,40,,µM,4.4,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532497,,61963990,21436072,,19747516,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532498,,457374,21436361,MAIN,17453735,AH075,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,52,,µM,4.28,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532499,,61963990,21436124,,19938559,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532500,,457374,21436357,MAIN,12266034,RM175,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532501,,61963990,21436064,,19747505,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532502,,457374,21436364,MAIN,17957696,AFAP51,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,7.6,,µM,5.12,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532503,,457374,21436371,MAIN,18016347,AFAP05,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,7,,µM,5.15,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532504,,61963990,21436071,,19747515,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532505,,457374,21436374,MAIN,18016377,AFAP65,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,9.4,,µM,5.03,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532506,,61963990,21436273,,19938727,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532507,,457374,21436358,MAIN,16682125,RF01,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532508,,61963990,21436271,,19938725,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532509,,457374,21436360,MAIN,17261738,AFAP29,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532510,,61963990,21436226,,19938671,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532511,,457374,21436362,MAIN,17492280,MM5,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532512,,61963990,21436333,,24183744,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532513,,457374,21436365,MAIN,18010532,AFAP60,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532514,,61963990,21436270,,19938724,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532515,,457374,21436372,MAIN,18016360,AFAP52,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532516,,61963990,21436193,,19938634,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532517,,457374,21436368,MAIN,18010678,AFAP43,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532518,,61963990,21436062,,19747503,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532519,,457374,21436369,MAIN,18010686,AFAP49,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532520,,61963990,21436276,,19938731,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532521,,61963990,21436187,,19938628,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532522,,457374,21436376,MAIN,18527716,AFAP44,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532523,,61963990,21436203,,19938646,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532524,,457374,21436377,MAIN,18527717,RF11,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532525,,61963990,21436141,,19938578,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532526,,457374,21436378,MAIN,18527718,AFAP23,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532527,,61963990,21436121,,19938556,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532528,,457374,21436379,MAIN,18527719,MM45,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532529,,61963990,21436247,,19938695,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532530,,457374,21436386,MAIN,18527726,RF16,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532531,,61963990,21436251,,19938701,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532532,,457374,21436389,MAIN,18527730,AH076,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532533,,61963990,21436250,,19938700,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532534,,457374,21436373,MAIN,18016375,AFAP55,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532535,,61963990,21436257,,19938710,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532536,,457374,21436375,MAIN,18016422,AFAP41,,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532537,,61963990,21436225,,19938670,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532538,,457374,21436359,MAIN,17010243,RF02(a),,,,,,,,7169084,IC50,,6089900,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532539,,61963990,21436219,,19938664,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532540,,457374,21436391,MAIN,18527733,8,,,,,,,,7169087,IC50,,6089901,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,8.2,,µM,5.09,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532541,,61963990,21436163,,19938602,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532542,,457374,21436390,MAIN,18527732,9,,,,,,,,7169087,IC50,,6089901,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,50,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532543,,61963990,21436101,,19938532,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532544,,457374,21436356,MAIN,11571517,2316131,,,,,,,,7169087,IC50,,6089901,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,~,0.5,,µM,6.3,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532545,,61963990,21436154,,19938593,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532546,,457374,21436381,MAIN,18527721,6,,,,,,,,7169080,IC50,,6089898,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,10 - 50,,µM,5,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532547,,61963990,21436201,,19938644,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532548,,457374,21436385,MAIN,18527725,4,,,,,,,,7169080,IC50,,6089898,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,,10 - 50,,µM,5,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532549,,61963990,21436068,,19747512,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532550,,457374,21436382,MAIN,18527722,3,,,,,,,,7169081,IC50,,6089898,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,50,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532551,,61963990,21436069,,19747513,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532552,,457374,21436383,MAIN,18527723,2,,,,,,,,7169081,IC50,,6089898,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,50,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532553,,61963990,21436140,,19938577,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532554,,457374,21436384,MAIN,18527724,1,,,,,,,,7169081,IC50,,6089898,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,50,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532555,,61963990,21436153,,19938592,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532556,,457374,21436387,MAIN,18527727,5,,,,,,,,7169081,IC50,,6089898,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806905,A2780 cell line,,,,human,,,,,,,,,,,human,,,,>,50,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532557,,61963990,21436285,,19938743,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532558,,457374,21436388,MAIN,18527728,AFAP40,,,,,,,,7169085,qualitative,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,the title compound shows cytotoxicity,,,,,,,,,,2018/11/16,,,2018/11/22,
52532559,,61963990,21436218,,19938663,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532560,,457374,21436363,MAIN,17627998,HC11,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,,0.5,,µM,6.3,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532561,,61963990,21436191,,19938632,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532562,,457374,21436364,MAIN,17957696,AFAP51,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,,10,,µM,5,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532563,,457374,21436371,MAIN,18016347,AFAP05,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,,10,,µM,5,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532564,,61963990,21436190,,19938631,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532565,,457374,21436366,MAIN,18010533,AFAP42,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,,17,,µM,4.77,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532566,,61963990,21436242,,19938687,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532567,,457374,21436357,MAIN,12266034,RM175,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,,3,,µM,5.52,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532568,,61963990,21436100,,19938531,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532569,,457374,21436374,MAIN,18016377,AFAP65,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,,6.4,,µM,5.19,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532570,,61963990,21436054,,19747494,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532571,,457374,21436367,MAIN,18010546,AFAP62,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,,60,,µM,4.22,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532572,,61963990,21436098,,19938529,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532573,,457374,21436370,MAIN,18010702,AFAP64,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,,8,,µM,5.1,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532574,,61963990,21436091,,19938519,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532575,,457374,21436355,MAIN,11329613,MMS6,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532576,,61963990,21436281,,19938739,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532577,,457374,21436360,MAIN,17261738,AFAP29,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532578,,61963990,21436280,,19938738,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532579,,457374,21436365,MAIN,18010532,AFAP60,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532580,,61963990,21436148,,19938586,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532581,,457374,21436372,MAIN,18016360,AFAP52,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532582,,61963990,21436246,,19938691,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532583,,457374,21436368,MAIN,18010678,AFAP43,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532584,,61963990,21436182,,19938623,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532585,,457374,21436369,MAIN,18010686,AFAP49,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532586,,61963990,21436215,,19938660,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532587,,457374,21436376,MAIN,18527716,AFAP44,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532588,,61963990,21436074,,19747518,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532589,,457374,21436378,MAIN,18527718,AFAP23,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532590,,61963990,21436202,,19938645,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532591,,457374,21436379,MAIN,18527719,MM45,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532592,,61963990,21436055,,19747495,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532593,,457374,21436380,MAIN,18527720,AFAP57,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532594,,61963990,21436173,,19938614,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532595,,61963990,21436241,,19938686,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532596,,457374,21436373,MAIN,18016375,AFAP55,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532597,,457374,21436375,MAIN,18016422,AFAP41,,,,,,,,7169086,IC50,,6089899,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532598,,61963990,21436176,,19938617,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532599,,457374,21436381,MAIN,18527721,6,,,,,,,,7169082,IC50,,6089897,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,,4.4,,µM,5.36,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532600,,61963990,21436278,,19938734,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532601,,457374,21436385,MAIN,18527725,4,,,,,,,,7169082,IC50,,6089897,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,,4.8,,µM,5.32,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532602,,61963990,21436152,,19938591,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532603,,61963990,21436138,,19938574,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532604,,457374,21436382,MAIN,18527722,3,,,,,,,,7169082,IC50,,6089897,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,50,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532605,,61963990,21436252,,19938702,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532606,,457374,21436383,MAIN,18527723,2,,,,,,,,7169082,IC50,,6089897,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,50,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532607,,61963990,21436318,,19938780,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532608,,457374,21436384,MAIN,18527724,1,,,,,,,,7169082,IC50,,6089897,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,50,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532609,,61963990,21436312,,19938772,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532610,,457374,21436387,MAIN,18527727,5,,,,,,,,7169082,IC50,,6089897,Cell/tumor cell: proliferation/viability/growth,Cytotoxicity,Toxicity/Safety Pharmacology,,,,Effect : cytotoxicity,Cytotoxic,1806904,A-549 cell line,,,,human,,,,,,,,,,,human,,,,>,50,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532611,,61963990,21436223,,19938668,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532612,,457374,21436394,MAIN,18043145,,,,,,,,,7169088,IC50,,6089902,,Cell/tumor cell: proliferation/viability/growth,Toxicity/Safety Pharmacology,,,,cytotoxicity,Cytotoxic,,,,,,,,,,,,,,,,,,,,,,8,,µM,5.1,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532613,,61963990,21436200,,19938642,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532614,,457374,21436392,MAIN,18043143,,,,,,,,,7169088,IC50,,6089902,,Cell/tumor cell: proliferation/viability/growth,Toxicity/Safety Pharmacology,,,,cytotoxicity,Cytotoxic,,,,,,,,,,,,,,,,,,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532615,,61963990,21436265,,19938719,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532616,,457374,21436393,MAIN,18043144,,,,,,,,,7169088,IC50,,6089902,,Cell/tumor cell: proliferation/viability/growth,Toxicity/Safety Pharmacology,,,,cytotoxicity,Cytotoxic,,,,,,,,,,,,,,,,,,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532617,,457374,21436394,MAIN,18043145,,,,,,,,,7169089,IC50,,6089903,,Cell/tumor cell: proliferation/viability/growth,Toxicity/Safety Pharmacology,,,,cytotoxicity,Cytotoxic,,,,,,,,,,,,,,,,,,,,,,4.2,,µM,5.38,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52532618,,61963990,21436058,,19747499,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532619,,457374,21436392,MAIN,18043143,,,,,,,,,7169089,IC50,,6089903,,Cell/tumor cell: proliferation/viability/growth,Toxicity/Safety Pharmacology,,,,cytotoxicity,Cytotoxic,,,,,,,,,,,,,,,,,,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532620,,61963990,21436292,,19938750,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532621,,457374,21436393,MAIN,18043144,,,,,,,,,7169089,IC50,,6089903,,Cell/tumor cell: proliferation/viability/growth,Toxicity/Safety Pharmacology,,,,cytotoxicity,Cytotoxic,,,,,,,,,,,,,,,,,,,,,>,100,,µM,1,pAur < 5,,,,2018/11/16,,,2020/03/17,
52532622,,61963990,21436309,,19938769,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532623,,61963990,21436092,,19938520,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532624,,61963990,21436090,,19938517,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532625,,61963990,21436073,,19747517,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532626,,61963990,21436067,,19747511,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532627,,61963990,21436306,,19938766,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532628,,61963990,21436287,,19938745,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532629,,61963990,21436216,,19938661,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532630,,61963990,21436260,,19938713,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532631,,61963990,21436131,,19938567,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532632,,61963990,21436293,,19938751,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532633,,61963990,21436114,,19938547,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532634,,61963990,21436132,,19938568,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532635,,61963990,21436168,,19938607,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532636,,61963990,21436147,,19938584,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532637,,61963990,21436177,,19938618,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532638,,61963990,21436249,,19938698,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532639,,61963990,21436210,,19938654,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532640,,61963990,21436105,,19938536,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532641,,61963990,21436117,,19938551,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532642,,61963990,21436245,,19938690,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532643,,61963990,21436261,,19938714,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532644,,61963990,21436133,,19938569,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532645,,61963990,21436189,,19938630,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532646,,61963990,21436102,,19938533,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532647,,61963990,21436336,,24183909,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532648,,61963990,21436337,,24183914,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532649,,61963990,21436262,,19938715,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532650,,61963990,21436209,,19938653,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532651,,61963990,21436122,,19938557,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532652,,61963990,21436175,,19938616,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532653,,61963990,21436052,,12668395,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532654,,61963990,21436277,,19938733,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532655,,61963990,21436206,,19938649,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532656,,61963990,21436194,,19938635,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532657,,61963990,21436165,,19938604,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532658,,61963990,21436248,,19938697,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532659,,61963990,21436239,,19938684,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532660,,61963990,21436230,,19938675,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532661,,61963990,21436236,,19938681,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532662,,61963990,21436110,,19938541,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532663,,61963990,21436338,,24183937,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532664,,61963990,21436053,,19747463,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532665,,61963990,21436300,,19938759,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532666,,61963990,21436308,,19938768,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532667,,61963990,21436063,,19747504,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532668,,61963990,21436180,,19938621,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532669,,61963990,21436171,,19938611,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532670,,61963990,21436188,,19938629,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532671,,61963990,21436160,,19938599,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532672,,61963990,21436207,,19938650,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532673,,61963990,21436233,,19938678,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532674,,61963990,21436211,,19938656,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532675,,61963990,21436227,,19938672,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532676,,61963990,21436065,,19747506,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532677,,61963990,21436066,,19747510,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532678,,61963990,21436348,,25548451,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532679,,61963990,21436057,,19747498,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532680,,61963990,21436235,,19938680,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532681,,61963990,21436161,,19938600,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532682,,61963990,21436158,,19938597,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532683,,61963990,21436264,,19938717,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532684,,61963990,21436186,,19938627,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532685,,61963990,21436256,,19938709,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532686,,61963990,21436172,,19938613,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532687,,61963990,21436149,,19938587,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532688,,61963990,21436221,,19938666,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532689,,61963990,21436263,,19938716,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532690,,61963990,21436113,,19938546,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532691,,61963990,21436166,,19938605,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532692,,61963990,21436237,,19938682,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532693,,61963990,21436274,,19938728,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532694,,61963990,21436174,,19938615,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532695,,61963990,21436125,,19938560,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532696,,61963990,21436224,,19938669,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532697,,61963990,21436127,,19938562,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532698,,61963990,21436139,,19938575,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532699,,61963990,21436142,,19938579,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532700,,61963990,21436111,,19938543,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532701,,61963990,21436178,,19938619,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532702,,61963990,21436302,,19938761,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532703,,61963990,21436294,,19938752,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532704,,61963990,21436243,,19938688,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532705,,61963990,21436244,,19938689,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532706,,61963990,21436116,,19938550,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532707,,61963990,21436335,,24183906,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532708,,61963990,21436103,,19938534,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532709,,61963990,21436109,,19938540,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532710,,61963990,21436169,,19938608,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532711,,61963990,21436086,,19938511,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532712,,61963990,21436238,,19938683,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532713,,61963990,21436213,,19938658,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532714,,61963990,21436279,,19938736,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532715,,61963990,21436259,,19938712,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532716,,61963990,21436087,,19938513,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532717,,61963990,21436099,,19938530,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532718,,61963990,21436085,,19938509,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532719,,61963990,21436088,,19938515,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532720,,61963990,21436089,,19938516,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532721,,61963990,21436080,,19938502,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532722,,61963990,21436094,,19938522,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532723,,61963990,21436081,,19938503,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
52532724,,61963990,21436342,,24184034,,,,,,,,,7169070,qualitative,,6089892,,Inhibitory activity,In Vitro (Efficacy),,,Inhibitor,Inhibitory activity of the compound against human CDK1-Cyclin B,,1806902,,,,,human,3844725,,Cyclin-dependent kinase 1 [human],human,Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human]:Wild,Cyclin-dependent kinase 1 [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Cyclin-dependent kinase 1 [human],1,2018/11/22,
